Boulder Innovation Center Bioscience Program Gets Boost From CU

Colorado Initiative in Molecular Biotechnology to Support BIC Commercialization
Process
BOULDER, Colo.--(Business Wire)--
The Boulder Innovation Center (BIC), as part its mission to commercialize
scientific inventions developed at the University of Colorado, has received
financial support from CU-Boulder`s CIMB (Colorado Initiative in Molecular
Biotechnology) to expand its Bioscience Program.

Tim Prodanovich, BIC Bioscience Program Manager, will be expanding his work with
CIMB faculty to identify promising commercial applications related to inventions
resulting from their research. CIMB is lead by Nobel Laureate and CU
Distinguished Professor Tom Cech and Director Dr. Leslie Leinwand. Prodanovich
will support commercialization programs in coordination with the CIMB and CU`s
Tech Transfer Office, focusing on Proof-of-Concept Proposal development;
business advisor, mentor and executive team recruitment; feasibility studies and
business planning; and capital formation strategies.

The CIMB was founded by CU-Boulder in 2003 to foster research, teaching and
technology development at the interfaces of the life sciences, physical
sciences, math, computational sciences and engineering. A major research and
teaching facility being built in the CU-Boulder Research Park will house the
CIMB as well as the Department of Chemical and Biological Engineering and the
Biochemistry Division. The 60 faculty and more than 600 researchers from a wide
variety of science, engineering and medical disciplines will collaborate with
each other and the biotech industry on high-tech solutions to biomedical
problems.

"We are pleased to partner with the Boulder Innovation Center`s Bioscience
Program in its efforts to commercialize inventions and technologies developed
through the Colorado Initiative in Molecular Biotechnology," said Cech. "Our
shared goal is to bolster biotechnology innovation in the region."

"With so many innovations on the horizon, investment in bioscience is poised for
growth," said Tim Bour, BIC executive director. "CU research excels in this
field, and the BIC`s Bioscience Program is ready to ramp up our support to help
commercialize these promising new technologies."

"From new technologies and companies, to workforce development and equity
funding, Colorado`s bioscience cluster is growing fast on every front," said
Prodanovich. "The BIC is looking forward to accelerating the CIMB`s commitment
to the research commercialization process."

Metzger Associates
John Metzger, 303-641-1062
john@metzger.com

Copyright Business Wire 2009